Axsome Therapeutics, Inc. - Common Stock (AXSM)
$127.09
0.00 (0.00%)
AXSM Stock Quote Delayed 30 Minutes
7 Small-Cap Growth Stocks With 1,000% Upside Potential
Here're 7 small-cap growth stocks with 1,000% upside potential. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
6.00B
PE Ratio
-21.22
EPS
-5.99
Volume (Avg. Vol.)
92
Day's Range
-
52-Week Range
$64.11 - $139.13
Dividend & Yield
N/A (N/A)
AXSM Stock Predictions, Articles, and Axsome Therapeutics, Inc. - Common Stock News
Why Is Axsome Therapeutics (AXSM) Stock Down Today?
Axsome Therapeutics (AXSM) stock is falling hard on Monday following a report about an upcoming decision from the FDA this week.
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's a new week and that means it's time for us to start it off with a look at the biggest pre-market stock movers for Monday!
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on Covid-19 and cryptocurrency stocks with the infrastructure bill up for a vote.
AXSM Stock: The Big FDA News Giving Axsome Therapeutics a Boost
AXSM stock is gaining on Monday after the FDA granted its new drug application priority review. Here's what you should know now.
Axsome Therapeutics News: AXSM Stock Rockets 76% on Depressive Disorder Drug Results
Axsome Therapeutics (AXSM) news for Monday about results from the company's Phase 3 Trial of AXS-05 has AXSM stock rocketing higher.
Axsome Therapeutics: Do Not Buy AXSM Stock After Its Monster Rally
No longer a penny stock, Axsome Therapeutics (AXSM) surged past $8 a share on news that its AXS-05 treatment affected a 17.2-point drop in patients on the Montgomery-Asbert Depression Rating Scale. But is it a buy?
AXSM News: Why Axsome Therapeutics Stock Is Skyrocketing Today
Axsome Therapeutics (AXSM) stock was flying high on Monday following some good AXSM news about a recent Phase 2 drug trial.
